Disparities in opioid overdose deaths continue to worsen for Black people, study suggests

NIH-supported study underscores the need for racially inclusive approach to address the opioid crisis in hard-hit areas
Source: NIDA News - Category: Addiction Tags: Addiction Science, African Americans, News Release, Evidence-Based Practices, Fentanyl, Health and Medical Professionals, Health Disparities, Heroin, Illicit Opioids, NIDAMED News, Opioids, Overdose, Researchers Source Type: news

Related Links:

AbstractProblemCriminal activity attributed to substance misuse is a tremendous challenge to public health and public safety. Over 80% of Alaska's incarcerated population has an addiction disorder. These individuals are 129 times more likely to die of a drug overdose within two weeks after reentry. Nearly 83% will likely be rearrested. This complex problem has a costly impact. In 2017, 25,450 Alaskans were victims of crimes directly attributed to substance misuse for a total cost of over $2.3 billion.DescriptionThe Alaska Recidivism Reduction and Recovery Project is a comprehensive intervention addressing the primary risk ...
Source: The European Journal of Public Health - Category: General Medicine Source Type: research
Provides public health training, scholarships, and stipends for individuals who are currently working with organizations in the areas of adolescent health, addiction and overdose, environmental challenges, obesity and the food system, and violence. Beginning in 2022, the Bloomberg Fellows program will support cohorts of Indigenous Scholars that are looking to use public health tools to address the most pressing issues in their communities. Geographic coverage: Nationwide -- Center for American Indian Health, Johns Hopkins Bloomberg School of Public Health
Source: Funding opportunities via the Rural Health Information Hub - Category: American Health Source Type: funding
Pharmacol Rev. 2021 Oct;73(4):98-126. doi: 10.1124/pharmrev.120.000046.ABSTRACTPain prevalence among adults in the United States has increased 25% over the past two decades, resulting in high health-care costs and impacts to patient quality of life. In the last 30 years, our understanding of pain circuits and (intra)cellular mechanisms has grown exponentially, but this understanding has not yet resulted in improved therapies. Options for pain management are limited. Many analgesics have poor efficacy and are accompanied by severe side effects such as addiction, resulting in a devastating opioid abuse and overdose epidemic....
Source: Pharmacological Reviews - Category: Drugs & Pharmacology Authors: Source Type: research
DISCUSSION: There is urgent public health need to improve the implementation of CM as an adjunct to medication for opioid use disorder. Consistent with its hybrid type 3 design, Project MIMIC is advancing implementation science by comparing impacts of these two multifaceted strategies on both implementation and patient outcomes, and by examining the extent to which the impacts of those strategies can be explained by putative mediators.TRIAL REGISTRATION: This clinical trial has been registered with clinicaltrials.gov (NCT03931174). Registered April 30, 2019. https://clinicaltrials.gov/ct2/show/NCT03931174?term=project+mimi...
Source: Addiction Science and Clinical Practice - Category: Addiction Authors: Source Type: research
CONCLUSIONS: Overall, existing research suggests people who use methamphetamine/amphetamines may have lower receipt of MOUD, retention in MOUD, and opioid abstinence during MOUD. Future research should examine how specific policies and treatment models impact MOUD outcomes for these patients, and seek to understand the perspectives of MOUD providers and people who use both opioids and methamphetamine/amphetamines. Efforts to improve MOUD care and overdose prevention strategies are needed for this population.PMID:34635170 | DOI:10.1186/s13722-021-00266-2
Source: Addiction Science and Clinical Practice - Category: Addiction Authors: Source Type: research
DISCUSSION: There is urgent public health need to improve the implementation of CM as an adjunct to medication for opioid use disorder. Consistent with its hybrid type 3 design, Project MIMIC is advancing implementation science by comparing impacts of these two multifaceted strategies on both implementation and patient outcomes, and by examining the extent to which the impacts of those strategies can be explained by putative mediators.TRIAL REGISTRATION: This clinical trial has been registered with clinicaltrials.gov (NCT03931174). Registered April 30, 2019. https://clinicaltrials.gov/ct2/show/NCT03931174?term=project+mimi...
Source: Addiction Science and Clinical Practice - Category: Addiction Authors: Source Type: research
CONCLUSIONS: Overall, existing research suggests people who use methamphetamine/amphetamines may have lower receipt of MOUD, retention in MOUD, and opioid abstinence during MOUD. Future research should examine how specific policies and treatment models impact MOUD outcomes for these patients, and seek to understand the perspectives of MOUD providers and people who use both opioids and methamphetamine/amphetamines. Efforts to improve MOUD care and overdose prevention strategies are needed for this population.PMID:34635170 | DOI:10.1186/s13722-021-00266-2
Source: Addiction Science and Clinical Practice - Category: Addiction Authors: Source Type: research
DISCUSSION: There is urgent public health need to improve the implementation of CM as an adjunct to medication for opioid use disorder. Consistent with its hybrid type 3 design, Project MIMIC is advancing implementation science by comparing impacts of these two multifaceted strategies on both implementation and patient outcomes, and by examining the extent to which the impacts of those strategies can be explained by putative mediators.TRIAL REGISTRATION: This clinical trial has been registered with clinicaltrials.gov (NCT03931174). Registered April 30, 2019. https://clinicaltrials.gov/ct2/show/NCT03931174?term=project+mimi...
Source: Addiction Science and Clinical Practice - Category: Addiction Authors: Source Type: research
CONCLUSIONS: Overall, existing research suggests people who use methamphetamine/amphetamines may have lower receipt of MOUD, retention in MOUD, and opioid abstinence during MOUD. Future research should examine how specific policies and treatment models impact MOUD outcomes for these patients, and seek to understand the perspectives of MOUD providers and people who use both opioids and methamphetamine/amphetamines. Efforts to improve MOUD care and overdose prevention strategies are needed for this population.PMID:34635170 | PMC:PMC8504567 | DOI:10.1186/s13722-021-00266-2
Source: Addiction Science and Clinical Practice - Category: Addiction Authors: Source Type: research
DISCUSSION: There is urgent public health need to improve the implementation of CM as an adjunct to medication for opioid use disorder. Consistent with its hybrid type 3 design, Project MIMIC is advancing implementation science by comparing impacts of these two multifaceted strategies on both implementation and patient outcomes, and by examining the extent to which the impacts of those strategies can be explained by putative mediators.TRIAL REGISTRATION: This clinical trial has been registered with clinicaltrials.gov (NCT03931174). Registered April 30, 2019. https://clinicaltrials.gov/ct2/show/NCT03931174?term=project+mimi...
Source: Addiction Science and Clinical Practice - Category: Addiction Authors: Source Type: research
More News: Addiction | African Health | Fentanyl | Overdose | Science | Study